Condensed Consolidated Interim Statements of Cash Flows (Unaudited) - USD ($)	9 Months Ended
	Sep. 30, 2025	Sep. 30, 2024
Operating activities
Net loss	$ (20,704,388)	$ (27,840,513)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation expense	141,743	195,483
Stock-based compensation expense	2,373,711	2,859,650
Interest expense	0	138,772
Deferred income tax benefit	0	(63,999)
Changes in current assets and liabilities:
Prepaid expenses and other current assets	(419,410)	(100,357)
Accounts payable and accrued liabilities	246,561	1,034,513
Other assets	0	(103,100)
Net cash used in operating activities	(18,361,783)	(23,879,551)
Investing activities
Purchases of property and equipment	(110,891)	(143,765)
Purchases of mineral rights and properties	(185,353)	(430,197)
Net cash used in investing activities	(296,244)	(573,962)
Financing activities
Proceeds from sale of common stock on at-the market ("ATM") program, net of issuance costs	7,316,230	7,673,146
Proceeds from common stock offering, net of issuance costs	32,684,881	0
Proceeds from Orion Equity Investment, net of issuance costs	0	5,705,926
Proceeds from exercise of options	96,000	38,400
Proceeds from exercise of warrants	2,960,157	0
Payments of income taxes on performance stock units ("PSUs"), restricted stock units ("RSUs") and shares issued for compensation	(785,458)	0
Proceeds from sale of royalty interest	0	182,758
Net cash provided by financing activities	42,271,810	13,600,230
Net change in cash and cash equivalents	23,613,783	(10,853,283)
Cash and cash equivalents, beginning of period	9,408,270	25,548,373
Cash and cash equivalents, end of period	33,022,053	14,695,090
Non-cash investing and financing activities
Amortization and expiration of deferred ATM offering costs offset against additional paid-in capital	(246,671)	(155,414)
Common stock issued for accrued bonuses	113,959	0
Common stock issued for purchase of mineral rights and properties	$ 0	$ 1,351,747